Schistosomiasis - Pipeline Landscape and Development in Therapeutics Analyzed for H1 2017

Published on : May 19, 2017

Albany, New York, May 19, 2017: Increased construction of vast dams and irrigation schemes has resulted in the massive outburst of water-borne infections, one of such diseases is schistosomiasis. Market Research Hub (MRH) has recently reviewed this infectious healthcare disease in detail and prepared a study titled as “Schistosomiasis - Pipeline Review, H1 2017” and added to its vast repository. The researched study provides the latest information on the current therapeutic landscape and pipeline analysis that offers an overview of the Schistosomiasis (Infectious Disease).

Schistosomiasis is an infectious disease caused by fresh water parasites (flatworm or schistosomes). People are mostly infected due to various activities such as routine agricultural, occupational, domestic, and recreational activities, which expose them to infected water. Un-hygiene and certain play habits of children such as swimming or fishing in infected water also make them vulnerable to infection. In brief, a person gets infected when larval forms of the parasite released by freshwater snails penetrate the skin during contact with the infected water. Also, the female schistosomes (flatworm) hatches an egg in the body of the infected person and the eggs can end up in the skin, brain, muscle, adrenal glands, eyes, female genital and urinary tract causing harm to the subsequent body part. The main symptoms include headache, a high temperature, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain. It is prevented by access to safe water, improved sanitation, hygiene education, and snail control.   

This report starts with the Schistosomiasis overview, therapeutic development and the companies & drugs involved in Schistosomiasis therapeutic development. The Schistosomiasis therapeutic development is discussed with pipeline overview, pipeline companies, pipeline by universities/institutes, products under development by companies and finally products under development by universities/institutes. Similarly, Schistosomiasis therapeutics assessment is explained in the report by route of administration and molecule type. Further, the main players or companies involved in the Schistosomiasis pipeline overview are listed, with top players including Kancera AB, LondonPharma Ltd., Merck KGaA and Salvensis.

Click here to get more info with TOC in a PDF Format :

The researched study has also profiled the Schistosomiasis drugs with product description, mechanism of action and R&D progress. The main drugs profiled are BDM-I, EDE-1102, intestinal schistosomiasis vaccine, L-Praziquantel, schistosomiasis vaccine and Small Molecule for Schistosomiasis. Further, the dormant and discontinued projects of the major players, Schistosomiasis product development milestones and featured news & press releases are detailed and discussed in the research. Finally, the report concludes with the list of tables and figures which provide systematic pictorial Schistosomiasis pipeline review based on various therapeutic development, therapeutic assessment and involved companies.

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top